RAB35 Human

RAB35, Member RAS Oncogene Family Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Characterization of RAB35

RAB35 is encoded by the RAB35 gene located on chromosome 12q24.31. The protein comprises 221 amino acids (25.1 kDa) and cycles between GTP-bound (active) and GDP-bound (inactive) states, mediated by guanine exchange factors (GEFs) and GTPase-activating proteins (GAPs) .

Membrane Trafficking and Endocytosis

RAB35 governs endocytic recycling, facilitating the return of cell surface receptors (e.g., integrins, cadherins) to the plasma membrane. Loss of RAB35 disrupts endocytosis and exocytosis, impairing processes like cytokinesis and neurite outgrowth .

Actin Cytoskeleton Regulation

RAB35 promotes actin bundling via interactions with Fascin and MICAL-L1, critical for embryogenesis, hippocampal neuronal migration, and TNT (tunneling nanotube) formation .

Disease Associations

  • Cancer: Oncogenic RAB35 mutations (e.g., Q67L) constitutively activate PI3K/AKT signaling, suppress apoptosis, and drive cellular transformation .

  • Neurodegeneration:

    • Parkinson’s Disease (PD): Elevated serum RAB35 correlates with younger disease onset and akinetic-rigid phenotypes .

    • Alzheimer’s Disease (AD): RAB35 downregulation increases amyloidogenic processing of APP by retaining BACE1 in endosomes .

  • Charcot-Marie-Tooth Disease (CMT): RAB35 interacts with myotubularins (MTMR2/MTMR13) to regulate mTORC1 signaling and myelin growth .

Table 2: RAB35 Dysregulation in Human Diseases

DiseaseMechanismClinical ImpactSource
PD↑ Serum RAB35 levelsYounger onset, motor severity
GlioblastomaRAB35 Q67L mutationPI3K/AKT hyperactivation
CMT Type 4BImpaired Rab35-MTMR2/13 interactionHypermyelination, nerve defects
AD↓ RAB35 expressionAβ accumulation, synaptic loss

Therapeutic Implications

  • Cancer: Targeting RAB35-PI3K/AKT axis with inhibitors like GDC-0941 suppresses tumor growth .

  • Neurodegeneration: AAV-mediated RAB35 overexpression rescues GC-induced amyloidogenesis and Tau pathology .

  • Myelin Disorders: Modulating Rab35-MTMR2/13 interactions could ameliorate CMT4B hypermyelination .

Research Gaps and Future Directions

  • Mechanistic Studies: Clarify RAB35’s role in TNT-mediated intercellular communication .

  • Biomarker Potential: Validate serum RAB35 as a PD diagnostic tool across diverse cohorts .

  • Drug Development: Screen small molecules targeting RAB35-effector interfaces .

Product Specs

Introduction
Rab-related protein Rab-35, also known as RAB35, is found exclusively in the plasma membrane and endocytic compartments. It plays a crucial role in regulating a rapid endocytic recycling pathway. When Rab35 function is inhibited, it disrupts the normal process of cell division, leading to the buildup of endocytic markers within numerous cytoplasmic vacuoles in cells that have not successfully completed cytokinesis. This observation highlights the critical role of Rab35-regulated recycling in cell division.
Description
Recombinant human RAB35, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 221 amino acids, with residues 1-201 representing the RAB35 sequence, and has a molecular weight of 25.2 kDa. The protein is fused to a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic methods.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The RAB35 protein is supplied in a solution containing 0.25 mg/ml of protein, 20 mM Tris-HCl buffer (pH 8.0), 40% glycerol, 0.15 M NaCl, and 1 mM DTT.
Stability
For short-term storage (2-4 weeks), the protein can be stored at 4°C. For extended storage, it is recommended to freeze the protein at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Avoid repeated freezing and thawing of the protein.
Purity
The purity of the RAB35 protein is determined to be greater than 90% using SDS-PAGE analysis.
Synonyms
Ras-related protein Rab-35, GTP-binding protein RAY, Ras-related protein Rab-1C, RAB35, RAB1C, RAY.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MARDYDHLFK LLIIGDSGVG KSSLLLRFAD NTFSGSYITT IGVDFKIRTV EINGEKVKLQ IWDTAGQERF RTITSTYYRG THGVIVVYDV TSAESFVNVK RWLHEINQNC DDVCRILVGN KNDDPERKVV ETEDAYKFAG QMGIQLFETS AKENVNVEEM FNCITELVLR AKKDNLAKQQ QQQQNDVVKL TKNSKRKKRC C.

Q&A

What is RAB35 and what are its primary cellular functions?

RAB35 is a member of the Rab family of small GTPases that functions as a master regulator of membrane trafficking. It cycles between inactive GDP-bound and active GTP-bound states, regulated by specific guanine-nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) . Functionally, RAB35 plays critical roles in:

  • Endocytic recycling of cargo at the plasma membrane-endosome interface

  • Regulation of actin cytoskeleton dynamics and organization

  • Formation of circular dorsal ruffles (CDRs) during cell migration

  • Control of epithelial cell adhesion and polarity

  • Cytokinesis during cell division

  • Regulation of primary cilia length and composition

The multifaceted role of RAB35 establishes it as a critical node in cellular homeostasis, with its dysfunction potentially contributing to developmental abnormalities and disease states.

How is RAB35 activity regulated in human cells?

RAB35 activity is primarily regulated through a cycle of GTP binding (activation) and hydrolysis (inactivation):

  • Activation: Mediated by GEFs from the connecdenn/DENND1 family, which catalyze the exchange of GDP for GTP

  • Inactivation: Facilitated by GAPs, particularly those from the TBC1D10/EPI64 family, which promote GTP hydrolysis

  • Membrane association: RAB35 associates with membranes via prenylation of its C-terminus

  • Effector binding: In its GTP-bound state, RAB35 interacts with numerous effector proteins that mediate its downstream functions

This regulatory cycle enables precise temporal and spatial control of RAB35-dependent processes, allowing for dynamic modulation of membrane trafficking and cytoskeletal organization in response to cellular needs.

What phenotypes result from RAB35 loss in mammalian models?

Studies using knockout mouse models have revealed that RAB35 is essential for mammalian development and tissue homeostasis:

  • Embryonic lethality: Congenital RAB35 knockout mice exhibit embryonic arrest at E7.5 with cardiac edema, demonstrating its essential role in early development

  • Kidney and ureter defects: Conditional deletion of RAB35 during gestation or postnatally causes non-obstructive hydronephrosis associated with:

    • Disrupted actin cytoskeletal architecture

    • Altered Arf6 epithelial polarity

    • Reduced adherens junctions

    • Loss of tight junction formation

    • Defects in EGFR expression and localization

    • Shortened primary cilia

  • Cellular migration defects: Loss of RAB35 impairs directed chemotactic migration and chemoinvasion in response to growth factor gradients

These phenotypes highlight RAB35's critical importance in developmental processes and tissue maintenance, particularly in epithelial structures.

How does RAB35 coordinate with the PI3K pathway to regulate chemotaxis?

RAB35 functions as a molecular determinant for controlling an excitable, oscillatory system that directs growth factor-mediated chemotaxis. The molecular coordination involves:

  • Direct regulation: RAB35 directly regulates the activity of the p85/PI3K polarity axis

  • Wave formation: RAB35 is necessary for the formation of growth factor-induced waves of circular dorsal ruffles (CDRs)

  • Excitable system properties: When activated, RAB35 induces recurrent and polarized CDRs that travel as propagating waves, exhibiting properties of an excitable system

  • Cell steering mechanism: This oscillatory behavior can be biased to control directional cell movement, effectively functioning as a "steering wheel" for chemotaxis

This coordination between RAB35 and PI3K provides cells with the ability to interpret noisy, shallow gradients of soluble cues, which is essential for effective chemotactic navigation.

What is the relationship between RAB35 and Arf6 in regulating epithelial cell polarity?

RAB35 and Arf6 exhibit an antagonistic relationship in regulating epithelial cell polarity and membrane protein trafficking:

  • Antagonistic regulation: RAB35 antagonizes Arf6, which functions to internalize surface proteins such as EGFR that inhibit cell adhesion and promote cell migration

  • Polarity maintenance: In RAB35 mutant kidney cells, Arf6 localization is disrupted, leading to altered epithelial polarity

  • Boundary formation: RAB35 appears to create an Arf6 apical boundary through regulation of Arf6 activity, which influences actin organization and E-cadherin localization on the baso-lateral membrane

  • Junction integrity: This regulation is necessary to maintain epithelial adherens junctions and subsequently tight junctions, as well as the localization of membrane receptors like EGFR

This antagonistic relationship provides a mechanism for the precise control of epithelial cell polarity, which is essential for tissue architecture and function.

How do the different RAB35 effector proteins mediate its diverse cellular functions?

RAB35 interacts with a plethora of effector proteins to mediate its diverse cellular functions:

  • Actin regulation effectors: Interact with RAB35 to control actin organization, critical for processes like cell migration, adhesion, and cytokinesis

  • Membrane trafficking effectors: Mediate RAB35's role in cargo recycling at endosomes

  • Cytoskeletal effectors: Enable RAB35 to influence cell shape, movement, and division

  • Polarity signaling effectors: Connect RAB35 to signaling pathways that establish and maintain cell polarity

Each effector protein likely mediates a specific subset of RAB35 functions, allowing this single GTPase to orchestrate diverse cellular processes in a coordinated manner. The specificity of these interactions and their regulation remains an active area of research.

What is the role of RAB35 in embryonic development and tissue homeostasis?

RAB35 plays essential roles in both embryonic development and the maintenance of tissue homeostasis:

  • Early embryogenesis: Congenital loss of RAB35 in mice causes embryonic arrest at E7.5, suggesting critical functions in gastrulation and early organogenesis

  • Epithelial integrity: RAB35 maintains epithelial structures in the urogenital system by regulating:

    • E-cadherin expression and localization

    • Formation and maintenance of cell-cell junctions

    • Actin cytoskeletal architecture

    • Proper localization of polarity markers like Arf6

  • Organ function: In the kidney and ureter, RAB35 is essential for maintaining normal architecture and function, with its loss leading to hydronephrosis

  • Cell differentiation: RAB35 appears to influence cell differentiation, as its loss leads to disrupted cell differentiation in kidney and ureter tissues

These roles highlight RAB35 as a critical regulator of both developmental processes and tissue maintenance throughout life.

How does RAB35 dysfunction contribute to disease pathogenesis?

While the search results don't provide direct information on human diseases associated with RAB35 dysfunction, the mouse model findings suggest several potential pathological mechanisms:

  • Developmental disorders: Given its essential role in embryonic development, RAB35 mutations could contribute to congenital abnormalities

  • Kidney disease: The non-obstructive hydronephrosis observed in RAB35 mutant mice suggests RAB35 dysfunction may contribute to similar kidney pathologies in humans

  • Cancer progression: RAB35 provides a novel link between Rab and Arf family GTPases with implications for tumor formation and invasiveness

  • Cell migration disorders: The role of RAB35 in chemotaxis suggests its dysfunction could affect processes requiring directed cell migration, such as wound healing or immune responses

These potential disease associations make RAB35 an important target for research in developmental biology, nephrology, and oncology.

What is the tissue-specific expression pattern of RAB35 and how does it relate to function?

RAB35 exhibits a dynamic expression pattern that changes during development and varies across tissues:

  • Embryonic expression: At E8.5, RAB35 is ubiquitously expressed, consistent with its essential role in early development

  • Postnatal expression: By P7, RAB35 expression becomes more restricted:

    • Highest expression in kidney, ureter, and testes

    • Modest expression in lung and liver

    • Minimal expression in heart and pancreas

  • Cellular distribution: Within expressing tissues, RAB35 is enriched in:

    • Epithelial cells

    • Ciliated cells (e.g., biliary epithelial cells and spermatozoa)

  • Intra-organ variation: In the kidney, RAB35 expression is not uniform, with greater activity in the cortex and renal papilla than in the medulla

This expression pattern aligns with the observed phenotypes in RAB35 mutant mice, particularly the prominent kidney and ureter defects, and suggests tissue-specific functions that may be explored in future research.

What are the optimal approaches for studying RAB35 activation and inactivation dynamics in living cells?

Investigating RAB35 activation and inactivation dynamics requires specialized techniques:

  • FRET-based biosensors: Design and implementation of fluorescence resonance energy transfer biosensors can allow real-time visualization of RAB35 activation states in living cells

  • Optogenetic tools: Light-controlled activation or inactivation of RAB35 enables precise temporal and spatial manipulation of its activity

  • GTP-locked and GDP-locked mutants: Generation of constitutively active (Q67L) or inactive (S22N) RAB35 mutants for functional studies

  • GEF/GAP manipulation: Overexpression or knockdown of specific RAB35 GEFs (connecdenn/DENND1 family) or GAPs (TBC1D10/EPI64 family) to modulate activation dynamics

  • Live cell imaging: Combined with fluorescently tagged RAB35 and its regulators/effectors to track subcellular localization and dynamics

These approaches can provide complementary insights into the spatial and temporal aspects of RAB35 regulation in different cellular contexts.

What experimental strategies can resolve contradictory findings regarding RAB35 function?

Resolving contradictory findings in RAB35 research requires systematic experimental approaches:

  • Context-dependent analysis: Investigate how cell type, developmental stage, or experimental conditions might influence RAB35 function

  • Acute vs. chronic manipulation: Compare acute depletion (e.g., using degron-based approaches) with long-term genetic knockout to distinguish between direct effects and compensatory responses

  • Isoform-specific targeting: Ensure that experimental manipulations target specific RAB35 isoforms if multiple exist

  • Effector-specific analysis: Systematically examine the contributions of different RAB35 effectors to specific cellular processes

  • Combined in vitro and in vivo approaches: Validate findings across multiple experimental systems, from cell lines to organoids to animal models

  • Quantitative measurements: Develop quantitative assays for specific RAB35 functions to allow more precise comparisons across studies

This systematic approach can help reconcile seemingly contradictory findings by uncovering the specific conditions under which different RAB35 functions predominate.

How can researchers effectively investigate the crosstalk between RAB35 and other GTPases?

Investigating crosstalk between RAB35 and other GTPases such as Arf6 requires specialized experimental strategies:

  • Sequential or simultaneous manipulation: Knockdown or overexpression of multiple GTPases in defined sequences to determine epistatic relationships

  • Proximity labeling approaches: BioID or APEX2-based proximity labeling to identify proteins in the vicinity of active RAB35

  • Co-immunoprecipitation studies: Investigate physical interactions between RAB35, its regulators, and other GTPases

  • Activity assays: Measure the activity of one GTPase while manipulating another to establish regulatory relationships

  • High-resolution microscopy: Super-resolution or FRET microscopy to visualize co-localization or direct interactions between different GTPases

  • Mathematical modeling: Develop computational models of GTPase networks to predict emergent behaviors and crosstalk mechanisms

These approaches can reveal how RAB35 functions within broader GTPase networks to coordinate complex cellular processes such as membrane trafficking, cytoskeletal dynamics, and cell polarity.

Product Science Overview

Structure and Function

RAB35 cycles between an inactive GDP-bound form and an active GTP-bound form. In its active state, it recruits various downstream effectors responsible for vesicle formation, movement, tethering, and fusion . This protein is essential for the fast recycling pathway back to the plasma membrane and is involved in the process of endocytosis . During cytokinesis, RAB35 is required for the postfurrowing terminal steps, including intercellular bridge stability and abscission .

Cellular Localization

RAB35 is located in several cellular components, including clathrin-coated endocytic vesicles, clathrin-coated pits, and intercellular bridges . It is also involved in the regulation of phosphatidylinositol 4,5-bisphosphate (PIP2) and SEPT2 localization at the intercellular bridge, which is crucial for cytokinesis .

Clinical Significance

Mutations or dysregulation of RAB35 have been associated with various diseases, including tetraploidy and bleeding disorder, platelet-type 19 . The gene is also involved in pathways related to Rab regulation of trafficking and vesicle-mediated transport .

Recombinant RAB35

The human recombinant RAB35 protein is produced in Escherichia coli and is a single, non-glycosylated polypeptide chain containing 221 amino acids. It has a molecular mass of approximately 25.2 kDa and is fused to a 20 amino acid His-tag at the N-terminus . This recombinant protein is purified using proprietary chromatographic techniques .

Research Applications

RAB35 is widely studied for its role in intracellular trafficking and its involvement in various cellular processes. It is also a subject of interest in cancer research due to its association with the RAS oncogene family. Researchers use recombinant RAB35 protein in various assays to study its function and interactions with other proteins.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.